Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Journal of the American College of Cardiology 75.2020, 2, S. 133-144, doi:10.1016/j.jacc.2019.10.057
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2020
- Creator
-
Bittner, Vera A.
Szarek, Michael
Aylward, Philip E.
Bhatt, Deepak L.
Diaz, Rafael
Edelberg, Jay M.
Fras, Zlatko
Goodman, Shaun G.
Halvorsen, Sigrun
Hanotin, Corinne
Harrington, Robert A.
Jukema, J. Wouter
Loizeau, Virginie
Moriarty, Patrick M.
Moryusef, Angèle
Pordy, Robert
Roe, Matthew T.
Sinnaeve, Peter
Tsimikas, Sotirios
Vogel, Robert
White, Harvey D.
Zahger, Doron
Zeiher, Andreas Michael
Schwartz, Gregory G.
- URN
-
urn:nbn:de:hebis:30:3-551543
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:52 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bittner, Vera A.
- Szarek, Michael
- Aylward, Philip E.
- Bhatt, Deepak L.
- Diaz, Rafael
- Edelberg, Jay M.
- Fras, Zlatko
- Goodman, Shaun G.
- Halvorsen, Sigrun
- Hanotin, Corinne
- Harrington, Robert A.
- Jukema, J. Wouter
- Loizeau, Virginie
- Moriarty, Patrick M.
- Moryusef, Angèle
- Pordy, Robert
- Roe, Matthew T.
- Sinnaeve, Peter
- Tsimikas, Sotirios
- Vogel, Robert
- White, Harvey D.
- Zahger, Doron
- Zeiher, Andreas Michael
- Schwartz, Gregory G.
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2020
Other Objects (12)
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Acute coronary syndrome : antithrombotic therapy and secondary prevention
Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis
TaqIB polymorphism in cholesterol ester transfer protein (CETP) gene predicts future cardiovascular death in patients experiencing an acute coronary syndrome
Identification of acute coronary syndrome via body-surface mapping and inverse electrocardiography
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis
Commentary on hostility and physiological responses to laboratory stress in acute coronary syndrome patients
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES Trial
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial
Cardiovascular aspects of Marfan syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Acute coronary syndrome : antithrombotic therapy and secondary prevention
Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis
TaqIB polymorphism in cholesterol ester transfer protein (CETP) gene predicts future cardiovascular death in patients experiencing an acute coronary syndrome
Identification of acute coronary syndrome via body-surface mapping and inverse electrocardiography
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis
Commentary on hostility and physiological responses to laboratory stress in acute coronary syndrome patients
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES Trial
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial
Cardiovascular aspects of Marfan syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Acute coronary syndrome : antithrombotic therapy and secondary prevention
Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis
TaqIB polymorphism in cholesterol ester transfer protein (CETP) gene predicts future cardiovascular death in patients experiencing an acute coronary syndrome
Identification of acute coronary syndrome via body-surface mapping and inverse electrocardiography
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis
Commentary on hostility and physiological responses to laboratory stress in acute coronary syndrome patients
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES Trial
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial